Literature DB >> 15179031

Contributions of the alpha6 integrins to breast carcinoma survival and progression.

Jun Chung1, Arthur M Mercurio.   

Abstract

This review summarizes recent findings that support a key role for the alpha6 integrins (alpha6beta1 and alpha6beta4) in the progression of breast carcinoma. The hypothesis that emerges from the existing data is that both of these integrins have the ability to sustain the survival of breast carcinoma cells, especially in stress conditions such as those that exist in the tumor microenvironment. The mechanisms by which these integrins promote survival appear to involve their ability to regulate the expression of vascular endothelial growth factor (VEGF), either at the level of transcription or translation. VEGF produced by breast carcinoma cells in response to alpha6 integrin regulation can function in an autocrine manner to promote survival signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15179031

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  17 in total

Review 1.  Integrin α3β1 as a breast cancer target.

Authors:  Sita Subbaram; C Michael Dipersio
Journal:  Expert Opin Ther Targets       Date:  2011-08-13       Impact factor: 6.902

2.  Neuropilin-2 regulates α6β1 integrin in the formation of focal adhesions and signaling.

Authors:  Hira Lal Goel; Bryan Pursell; Clive Standley; Kevin Fogarty; Arthur M Mercurio
Journal:  J Cell Sci       Date:  2012-02-02       Impact factor: 5.285

3.  α6-Integrin is required for the adhesion and vasculogenic potential of hemangioma stem cells.

Authors:  David M Smadja; Coralie L Guerin; Elisa Boscolo; Ivan Bieche; John B Mulliken; Joyce Bischoff
Journal:  Stem Cells       Date:  2014-03       Impact factor: 6.277

4.  Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue.

Authors:  Patricia E Burger; Xiaozhong Xiong; Sandra Coetzee; Sarah N Salm; David Moscatelli; Ken Goto; E Lynette Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-17       Impact factor: 11.205

5.  Role of CD9 in proliferation and proangiogenic action of human adipose-derived mesenchymal stem cells.

Authors:  Yeon Jeong Kim; Ji Min Yu; Hye Joon Joo; Hoe Kyu Kim; Hyun Hwa Cho; Yong Chan Bae; Jin Sup Jung
Journal:  Pflugers Arch       Date:  2007-08-01       Impact factor: 3.657

6.  CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization.

Authors:  Xiuwei H Yang; Andrea L Richardson; Maria I Torres-Arzayus; Pengcheng Zhou; Chandan Sharma; Alexander R Kazarov; Milena M Andzelm; Jack L Strominger; Myles Brown; Martin E Hemler
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

7.  Expression of integrin alpha6beta1 enhances tumorigenesis in glioma cells.

Authors:  Estelle Delamarre; Salma Taboubi; Sylvie Mathieu; Caroline Bérenguer; Véronique Rigot; Jean-Claude Lissitzky; Dominique Figarella-Branger; L'houcine Ouafik; José Luis
Journal:  Am J Pathol       Date:  2009-07-02       Impact factor: 4.307

8.  Expression of laminin isoforms, receptors, and binding proteins unique to nucleus pulposus cells of immature intervertebral disc.

Authors:  Jun Chen; Liufang Jing; Christopher L Gilchrist; William J Richardson; Robert D Fitch; Lori A Setton
Journal:  Connect Tissue Res       Date:  2009       Impact factor: 3.417

9.  The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy.

Authors:  Xinjie Lu; Dong Lu; Mike Scully; Vijay Kakkar
Journal:  Perspect Medicin Chem       Date:  2008-04-10

10.  Integrin alpha6Bbeta4 inhibits colon cancer cell proliferation and c-Myc activity.

Authors:  Anders Bondo Dydensborg; Inga C Teller; Jean-François Groulx; Nuria Basora; Fréderic Paré; Elizabeth Herring; Rémy Gauthier; Dominique Jean; Jean-François Beaulieu
Journal:  BMC Cancer       Date:  2009-07-09       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.